Back to search
FDAFDA · Food and drugs·Recall number D-1490-2019

Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL Bottle, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-435-01.

Published July 24, 2019 · Recall initiated: July 11, 2019

Summary

FDA records drug Class III recall D-1490-2019, published July 24, 2019 and initiated July 11, 2019. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 17,238 bottles; Lot: Lot #: H805157, Exp. 05/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Missing label; Product complaints reported missing bottle label.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide in the U.S. and PR.
Lot
Lot #: H805157, Exp. 05/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL Bottle, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-435-01. recalled?

Yes. FDA published recall D-1490-2019 on July 24, 2019. Reported hazard: Labeling: Missing label; Product complaints reported missing bottle label.

What should I do if I have this product?

Voluntary: Firm initiated · Letter